These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 35233952)

  • 1. Tumour-derived extracellular vesicle membrane hybrid lipid nanovesicles enhance siRNA delivery by tumour-homing and intracellular freeway transportation.
    Zhou X; Miao Y; Wang Y; He S; Guo L; Mao J; Chen M; Yang Y; Zhang X; Gan Y
    J Extracell Vesicles; 2022 Mar; 11(3):e12198. PubMed ID: 35233952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing of a suitable protocol for isolating tissue-derived extracellular vesicles and profiling small RNA patterns in hepatocellular carcinoma.
    Yang W; Liu Y; Wang J; Liu T; Tian T; Li T; Ding L; Chen W; Wang H; Zhu J; Zhang C; Pan B; Zhou J; Fan J; Wang B; Yang X; Guo W
    Liver Int; 2024 Oct; 44(10):2672-2686. PubMed ID: 39037259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation.
    Baldari S; Di Rocco G; Magenta A; Picozza M; Toietta G
    Cells; 2019 Dec; 8(12):. PubMed ID: 31816923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles.
    Deng J; Ke H
    Oncoimmunology; 2023; 12(1):2152635. PubMed ID: 36605619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered extracellular vesicles with synthetic lipids via membrane fusion to establish efficient gene delivery.
    Jhan YY; Prasca-Chamorro D; Palou Zuniga G; Moore DM; Arun Kumar S; Gaharwar AK; Bishop CJ
    Int J Pharm; 2020 Jan; 573():118802. PubMed ID: 31715354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximizing liposome tumor delivery by hybridizing with tumor-derived extracellular vesicles.
    Sulthana S; Shrestha D; Aryal S
    Nanoscale; 2024 Sep; 16(35):16652-16663. PubMed ID: 39171636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
    Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
    Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular-vesicles delivered tumor-specific sequential nanocatalysts can be used for MRI-informed nanocatalytic Therapy of hepatocellular carcinoma.
    Wu H; Xing H; Wu MC; Shen F; Chen Y; Yang T
    Theranostics; 2021; 11(1):64-78. PubMed ID: 33391461
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles.
    Evers MJW; van de Wakker SI; de Groot EM; de Jong OG; Gitz-François JJJ; Seinen CS; Sluijter JPG; Schiffelers RM; Vader P
    Adv Healthc Mater; 2022 Mar; 11(5):e2101202. PubMed ID: 34382360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma.
    Yao Y; Wang T; Liu Y; Zhang N
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1374-1383. PubMed ID: 30977418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D models.
    Xu J; Gu M; Hooi L; Toh TB; Thng DKH; Lim JJ; Chow EK
    Nanoscale; 2021 Oct; 13(38):16131-16145. PubMed ID: 34542130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma.
    Huang KW; Lai YT; Chern GJ; Huang SF; Tsai CL; Sung YC; Chiang CC; Hwang PB; Ho TL; Huang RL; Shiue TY; Chen Y; Wang SK
    Biomacromolecules; 2018 Jun; 19(6):2330-2339. PubMed ID: 29808997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP.
    Yang Y; Mao F; Guo L; Shi J; Wu M; Cheng S; Guo W
    Dig Liver Dis; 2021 Apr; 53(4):474-485. PubMed ID: 33563583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular Vesicles.
    Haraszti RA; Miller R; Didiot MC; Biscans A; Alterman JF; Hassler MR; Roux L; Echeverria D; Sapp E; DiFiglia M; Aronin N; Khvorova A
    Mol Ther; 2018 Aug; 26(8):1973-1982. PubMed ID: 29937418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.
    Zhong J; Huang HL; Li J; Qian FC; Li LQ; Niu PP; Dai LC
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):82-9. PubMed ID: 25655295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression.
    Pi F; Binzel DW; Lee TJ; Li Z; Sun M; Rychahou P; Li H; Haque F; Wang S; Croce CM; Guo B; Evers BM; Guo P
    Nat Nanotechnol; 2018 Jan; 13(1):82-89. PubMed ID: 29230043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing Extracellular Vesicles Generated from the Integra CELLine Culture System and Their Endocytic Pathways for Intracellular Drug Delivery.
    Geng T; Tian L; Paek SY; Leung E; Chamley LW; Wu Z
    Pharmaceutics; 2024 Sep; 16(9):. PubMed ID: 39339242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.